New automated sedation system aims to use less medicine in ICU

NCT ID NCT06187545

Completed Symptom relief Sponsor: University of Chile Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested a prototype device that automatically gives the sedative propofol to deeply sedated patients in the ICU who are on breathing machines. The goal was to see if the device could keep patients at the right sedation level while using less medication compared to usual care. Twenty patients took part, and the study compared the amount of propofol used and sedation levels between the two approaches.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: propofol
What this could lead to: If it works, this could lead to a smarter way to sedate ICU patients, using less medication and possibly reducing side effects.
What could go wrong: This is a very small pilot study with only 20 patients, so results may not apply to everyone. The device is still a prototype and may not work better than usual care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEEP SEDATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEEP SEDATION

Contacts and locations

Locations

Centro de Investigación Cínica Avanzada (CICA), Hospital Clinico de la Universidad de Chile

Santiago, RM, 7690306, Chile
Hospital Base San José Osorno

Osorno, Los Lagos Region, Chile
Hospital Clinico de la Universidad de Chile

Santiago, RM, 7690306, Chile

More trials for these conditions

Other studies related to the condition(s) this trial covers.